Initial data from the first phase 1 trial of the bispecific antibody FS222 demonstrate that it is a drug with a manageable safety profile and promising antitumour activity, especially in patients with metastatic cutaneous ...
Jun 3, 2024
0
0
A novel immunotherapy approach developed by Ludwig Cancer Research scientists employs a two-pronged attack against solid tumors to boost the immune system's ability to target and eliminate cancer cells.
Jun 3, 2024
0
20
Immunotherapy before surgery for patients with metastatic melanoma appears to be especially successful. Some 59% of patients respond so well to this therapy that adjuvant treatment is no longer needed, according to the results ...
Jun 3, 2024
0
1
Exposure to increased neighborhood violence has the power to change the glucocorticoid receptor (GR) for the stress hormone, cortisol, which may influence the aggressiveness of lung cancer, according to data presented at ...
Jun 3, 2024
0
0
In a new study, Yale researchers describe how a novel chemical compound attacks drug-resistant brain tumors without harming healthy surrounding tissue.
Jun 3, 2024
0
28
Researchers have revealed a new method to significantly enhance the efficacy of bispecific antibody therapies in treating solid tumors. Their findings were published on May 13 in Cell Reports Medicine.
May 31, 2024
0
21
A Johns Hopkins University-led research team has designed a method to generate enormous datasets of artificial, automatically annotated liver tumors on CT scans, enabling artificial intelligence models to be trained to accurately ...
May 31, 2024
0
9
Little is known about the genetics and biology of chordoma, a rare and aggressive bone tumor. Chordomas occur in approximately one in a million people in the U.S. a year and 5% of these are in children. These tumors can arise ...
May 31, 2024
0
16
For a large percentage of men with prostate cancer, the tumor may be so slow-growing that doctors advise a "watch-and-wait" approach instead of active treatment.
May 30, 2024
0
8
A recent study focuses on the Ly-6 antigens, a family of proteins that contain a conserved LU domain. These antigens have been associated with stem cells and cancer stem cells. The mouse Ly-6A (also known as Sca-1) is a well-known ...
May 30, 2024
0
0
